Resources

Welcome to the Resources hub. Here, you will find a range of materials (videos, slide decks, documents etc.) as well as interactive learning tools to support your clinical practice and medical education.

Our resources are organised by category. Simply expand the sections below to browse the related materials.

Disease Management

 

Antibody-Based Cancer Treatments

Kinase Inhibitors as Cancer Treatments

Introduction to chronic lymphocytic leukaemia (CLL)

Clinical course on chronic lymphocytic leukaemia (CLL)

Diagnosis of chronic lymphocytic leukaemia (CLL)

Chronic lymphocytic leukaemia (CLL) prognosis

Best practice chronic lymphocytic leukaemia (CLL) monitoring and follow-up guidance for HCPs

Mutational landscape of chronic lymphocytic leukaemia (CLL) and its impact on prognosis and treatment

Protecting patients with chronic lymphocytic leukaemia (CLL) from infections

Diagnosis and management of autoimmune cytopenias in chronic lymphocytic leukaemia (CLL)

Good practice in diagnosis and management of Richter's transformation

Patient Journey

 

Chronic lymphocytic lekaemia (CLL) diagnosis: initial consultation of suspected CLL

Active monitoring of chronic lymphocytic leukaemia (CLL): watch and wait strategy

Managing a chronic lymphocytic leukaemia (CLL) relapse

Treatment response assessment in chronic lymphocytic leukaemia (CLL)

Treatment response assessment checklist for patients with chronic lymphocytic lekaemia (CLL)

Initiating treatment in chronic lymphocytic leukaemia (CLL) patients

T-Cell Therapies in Haematology

Antibody-Based Cancer Treatments

Kinase Inhibitors as Cancer Treatments

CAR-Ts, BiTEs, and TILs as Cancer Treatments

Non-Hodgkin lymphoma (NHL) causes, symptoms, clinical presentation, and diagnosis

Demystifying the complexity of Hodgkin lymphoma (HL) and non-Hodgkin Lymphoma (NHL) classification

Treatments that target B cell receptor signalling and the B-cell lymphoma 2 protein (BCL2)

Importance of biomarker testing in diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL)

Module 1: An overview of mantle cell lymphoma (MCL)

Clinical features of mantle cell lymphoma (MCL)

Module 3: Mantle cell lymphoma (MCL) diagnosis

Module 4: Mantle cell lymphoma (MCL) prognosis, staging, and risk stratification

Supportive care considerations for haematological malignancies

Education and holistic needs assessment in chronic lymphocytic leukaemia (CLL) patient care

What is shared decision making?

Shared decision making in haematology-oncology

Undertaking geriatric oncology assessments in haematological malignancies

Advanced care planning guidance in haematology-oncology

Psychological impact of a chronic lymphocytic leukaemia (CLL) diagnosis

Psychological impact of watch and wait/active chronic lymphocytic leukaemia (CLL) treatment

Screening chronic lymphocytic leukaemia (CLL) patients for psychological distress and responding to their needs

Psychological support for chronic lymphocytic leukaemia (CLL) patients

Broader considerations in the management of chronic lymphocytic leukaemia (CLL)

Effective ways of collaborative working to enhance care of patients living with chronic lymphocytic lekaemia (CLL)

A cancer patient's journey into early phase clinical trials

Patient and public involvement in cancer research

A patient’s clinical trial journey, barriers to participation, and novel interventions to overcome them

Post-ASH 2025: Highlights in Acute Lymphoblastic Leukaemia

Post-ASH 2025: Highlights in Relapsed/Refractory DLBCL

Post-ASH 2025: Highlights in Follicular Lymphoma

Post-ASH 2025: Highlights in Acute Lymphoblastic Leukaemia

Post-ASH 2025: Highlights in Front-Line DLBCL

Post-ASH 2025: Highlights in Relapsed/Refractory Chronic Lymphocytic Leukaemia

Post-ASH 2025: Highlights in Untreated Chronic Lymphocytic Leukaemia

Post-ASH 2025: Highlights in Follicular Lymphoma - Data with bispecifics

iwCLL 2025 Highlights Podcast

Post-EHA and ICML 2025:
Highlights in Lymphoma Panel Discussion

ICML 2025 Highlights: NHL

ICML 2025 Highlights: Hodgkin’s Lymphoma

EHA and ICML 2025 Highlights: CLL

ICML 2025 Summary Highlights: CLL

EHA 2025 Highlights: T-ALL

EHA 2025 Highlights: B-ALL

EHA 2025 Highlights: Multiple Myeloma

ASH24 Highlight Video: Follicular Lymphoma

ASH24 Highlight Video: Diffuse Large B-Cell Lymphoma

ASH24 Highlight Video: Mantle Cell Lymphoma

ASH 2023 Highlights: Hodgkin's lymphoma data in UK clinical practice

ASH 2023 Highlights: Chemotherapy-free treatment options for follicular lymphoma

ASH 2023 Highlights: Bispecific agents in diffuse large B cell lymphoma (DLBCL)

ASH 2023 Highlights: ctDNA for diagnostics and prognostics in UK clinical practice

ASH 2023 Highlights: POD24 in mantle cell lymphoma (MCL)

ASH 2023 Highlights: ctDNA in high-grade lymphomas

ASH 2023 Highlights: Diffuse large B cell lymphoma (DLBCL) real-world and prospective data

CPD® Accreditation

To support your continued professional development the resources hosted in the Resources hub have been certified for CPD® accreditation by the CPD® Certification Service.

Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.